-
1
-
-
72949116366
-
Regulation of cell signalling by uPAR
-
20027185 10.1038/nrm2821 1:CAS:528:DC%2BD1MXhsFymtb7M
-
Smith HW, Marshall CJ (2010) Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 11:23-36
-
(2010)
Nat Rev Mol Cell Biol
, vol.11
, pp. 23-36
-
-
Smith, H.W.1
Marshall, C.J.2
-
2
-
-
74949099621
-
Urokinase plasminogen activator system as a potential target for cancer therapy
-
19903074 10.2217/fon.09.108 1:CAS:528:DC%2BD1MXhsVWhtrjK
-
Mekkawy AH, Morris DL, Pourgholami MH (2009) Urokinase plasminogen activator system as a potential target for cancer therapy. Future Oncol 5:1487-1499
-
(2009)
Future Oncol
, vol.5
, pp. 1487-1499
-
-
Mekkawy, A.H.1
Morris, D.L.2
Pourgholami, M.H.3
-
3
-
-
84859812544
-
The urokinase system in the pathogenesis of atherosclerosis
-
22137664 10.1016/j.atherosclerosis.2011.10.044 1:CAS:528: DC%2BC38XlvFynsr0%3D
-
Fuhrman B (2012) The urokinase system in the pathogenesis of atherosclerosis. Atherosclerosis 222:8-14
-
(2012)
Atherosclerosis
, vol.222
, pp. 8-14
-
-
Fuhrman, B.1
-
4
-
-
83655163681
-
Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease
-
22075245 10.1161/ATVBAHA.111.234369
-
Kiyan Y, Limbourg A, Kiyan R, Tkachuk S, Limbourg FP, Ovsianikov A, Chichkov BN, Haller H, Dumler I (2011) Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease. Arterioscler Thromb Vasc Biol 32:110-122
-
(2011)
Arterioscler Thromb Vasc Biol
, vol.32
, pp. 110-122
-
-
Kiyan, Y.1
Limbourg, A.2
Kiyan, R.3
Tkachuk, S.4
Limbourg, F.P.5
Ovsianikov, A.6
Chichkov, B.N.7
Haller, H.8
Dumler, I.9
-
5
-
-
64849116076
-
Serine proteases, inhibitors and receptors in renal fibrosis
-
19350108 1:CAS:528:DC%2BD1MXltVertLg%3D
-
Eddy AA (2009) Serine proteases, inhibitors and receptors in renal fibrosis. Thromb Haemost 101:656-664
-
(2009)
Thromb Haemost
, vol.101
, pp. 656-664
-
-
Eddy, A.A.1
-
6
-
-
38049032013
-
Modification of kidney barrier function by the urokinase receptor
-
18084301 10.1038/nm1696 1:CAS:528:DC%2BD1cXisVWjtA%3D%3D
-
Wei C, Möller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP et al (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14:55-63
-
(2008)
Nat Med
, vol.14
, pp. 55-63
-
-
Wei, C.1
Möller, C.C.2
Altintas, M.M.3
Li, J.4
Schwarz, K.5
Zacchigna, S.6
Xie, L.7
Henger, A.8
Schmid, H.9
Rastaldi, M.P.10
-
7
-
-
79961132981
-
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
-
21804539 10.1038/nm.2411 1:CAS:528:DC%2BC3MXpsFOjs7k%3D
-
Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M et al (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952-960
-
(2011)
Nat Med
, vol.17
, pp. 952-960
-
-
Wei, C.1
El Hindi, S.2
Li, J.3
Fornoni, A.4
Goes, N.5
Sageshima, J.6
Maiguel, D.7
Karumanchi, S.A.8
Yap, H.K.9
Saleem, M.10
-
8
-
-
84884211336
-
The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury
-
doi: 10.1007/s00109-012-0960-6
-
Zhang B, Shi W, Ma J, Sloan A, Faul C, Wei C, Reiser J, Yang Y, Liu S, Wang W (2012) The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med (Berl). doi: 10.1007/s00109-012-0960-6
-
(2012)
J Mol Med (Berl)
-
-
Zhang, B.1
Shi, W.2
Ma, J.3
Sloan, A.4
Faul, C.5
Wei, C.6
Reiser, J.7
Yang, Y.8
Liu, S.9
Wang, W.10
-
9
-
-
84862119511
-
Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria
-
22076430 10.1093/ndt/gfr612 1:CAS:528:DC%2BC38XmvVeisbo%3D
-
Zhang B, Xie S, Shi W, Yang Y (2012) Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria. Nephrol Dial Transplant 27:1746-1755
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 1746-1755
-
-
Zhang, B.1
Xie, S.2
Shi, W.3
Yang, Y.4
|